Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification

• Main Authors: Joan Perelló (Author), Joan Alberti (Author), Juan Vicente Torres (Author), Miguel D. Ferrer (Author), M. Mar Perez (Author), Firas Bassissi (Author), Alex Gold (Author), Paolo Raggi (Author), Glenn M. Chertow (Author), Carolina Salcedo (Author)
• פורמט: ספר
• יצא לאור: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Background: Patients receiving dialysis have high cardiovascular risk in part due to extensive vascular calcification. In the CaLIPSO study, infusion of hexasodium fytate (SNF472), the hexasodium salt of inositol hexaphosphate, for 52 weeks thrice weekly during hemodialysis significantly reduced pro...